
|Articles|August 15, 2003
FDA studies epikeratome refractive surgery device
Atlanta-The FDA is reviewing a pre-market notification from CIBA Vision Corp. for an epikeratome device for use in sub-epithelial separation.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope Therapeutics releases positive 3-year follow-up data from REMAIN study
2
FDA issues Complete Response Letter to Sydnexis for SYD-101 pediatric myopia treatment
3
Development of maculopathy associated with systemic medications
4
Periorbital rejuvenation: Past, present, and next
5

















































.png)


